From October 28, 2021 to December 31, 2021, the company has repurchased 15,335,700 shares, representing 0.98% for ¥49,979.94 million. With this, the company has completed the repurchase of 15,335,700 shares, representing 0.98% for ¥49,979.94 million under the buyback announced on October 28, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,125 JPY | -0.43% | +0.88% | +1.75% |
30/04 | Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion | RE |
26/04 | EU Panel Backs Approval of Takeda’s Colorectal Cancer Drug | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.75% | 42.08B | |
+26.08% | 681B | |
+21.85% | 556B | |
-4.77% | 361B | |
+16.97% | 325B | |
+5.69% | 285B | |
+13.68% | 235B | |
+3.65% | 199B | |
-11.12% | 189B | |
-3.40% | 157B |
- Stock Market
- Equities
- 4502 Stock
- News Takeda Pharmaceutical Company Limited
- Tranche Update on Takeda Pharmaceutical Company Limited's Equity Buyback Plan announced on October 28, 2021.